Pr Teike - Cell Impact Chief Officer
| CI Stock | 0.18 0.01 5.88% |
Executive
Pr Teike is Chief Officer of Cell Impact AB
| Age | 61 |
| Phone | 46 58 65 74 50 |
| Web | https://www.cellimpact.com |
Cell Impact Management Efficiency
The company has return on total asset (ROA) of (0.1956) % which means that it has lost $0.1956 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4056) %, meaning that it generated substantial loss on money invested by shareholders. Cell Impact's management efficiency ratios could be used to measure how well Cell Impact manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | EXECUTIVE Age | ||
| Jeffrey Pott | AstraZeneca PLC | N/A | |
| Katarina Ageborg | AstraZeneca PLC | N/A | |
Management Performance
| Return On Equity | -0.41 | |||
| Return On Asset | -0.2 |
Cell Impact AB Leadership Team
Elected by the shareholders, the Cell Impact's board of directors comprises two types of representatives: Cell Impact inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cell. The board's role is to monitor Cell Impact's management team and ensure that shareholders' interests are well served. Cell Impact's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cell Impact's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tord Latt, Chief Officer | ||
| Stefan Axellie, Chief Officer | ||
| Daniel Vallin, Chief Officer | ||
| Shigeru Nakagawa, Managing Inc | ||
| Pr Teike, Chief Officer | ||
| Karina Larsson, Chief Officer | ||
| Anders berg, Chief Officer |
Cell Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cell Impact a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.41 | |||
| Return On Asset | -0.2 | |||
| Profit Margin | (1.22) % | |||
| Operating Margin | (1.19) % | |||
| Current Valuation | 821.62 M | |||
| Shares Outstanding | 75.83 M | |||
| Shares Owned By Insiders | 17.07 % | |||
| Shares Owned By Institutions | 13.68 % | |||
| Price To Book | 2.79 X | |||
| Price To Sales | 11.09 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cell Stock Analysis
When running Cell Impact's price analysis, check to measure Cell Impact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cell Impact is operating at the current time. Most of Cell Impact's value examination focuses on studying past and present price action to predict the probability of Cell Impact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cell Impact's price. Additionally, you may evaluate how the addition of Cell Impact to your portfolios can decrease your overall portfolio volatility.